A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 3, Iss. 1, 2013-12 ,pp. : 459-467

Karger

Access to resources Recommend Favorite

The AMPA Antagonist ZK 200775 in Patients with Acute Ischaemic Stroke: A Double-Blind, Multicentre, Placebo-Controlled Safety and Tolerability Study

By  

Cerebrovascular Diseases, Vol. 20, Iss. 5, 2005-11 ,pp. : 304-309

Karger

Access to resources Recommend Favorite

The efficacy of cevimeline hydrochloride in the treatment of xerostomia in Sjögren’s syndrome in southern Chinese patients: a randomised double-blind, placebo-controlled crossover study

By Leung K.   McMillan A.   Wong M.   Leung W.   Mok M.   Lau C.  

Clinical Rheumatology, Vol. 27, Iss. 4, 2008-04 ,pp. : 429-436

Springer Publishing Company

Access to resources Recommend Favorite

A Double-Blind Placebo-Controlled Study of the Effects of Amphetamine and Physiotherapy after Stroke

By  

Cerebrovascular Diseases, Vol. 12, Iss. 3, 2001-10 ,pp. : 253-257

Karger

Access to resources Recommend Favorite

The Lescol^® Intervention Prevention Study (LIPS): a double-blind, placebo-controlled, randomized trial of the long-term effects of fluvastatin after successful transcatheter therapy in patients with coronary heart disease

By Serruys Patrick WJC   de Feyter Pim J   Benghozi Renée   Hugenholtz Paul G   Lesaffre Emmanuel  

International Journal of Cardiovascular Interventions, Vol. 4, Iss. 4, 2001-12 ,pp. : 165-172

Informa Healthcare

Access to resources Recommend Favorite